Guidelines of care for the management of atopic dermatitis : Section 4. Prevention of disease flares and use of adjunctive therapies and approaches

@@113053@@EM|consulte.

Article

Article Outline

Access to the text (HTML)

Access to the PDF text

Recommend this article

Save as favorites

Advertising

Access to the full text of this article requires a subscription.

If you are a subscriber, please sign in 'My Account' at the top right of the screen.

If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Volume 71, n° 6
pages 1218-1233 (décembre 2014)

Doi : 10.1016/j.jaad.2014.08.038

accepted : 22 August 2014

From the Academy

Guidelines of care for the management of atopic dermatitis : Section 4. Prevention of disease flares and use of adjunctive therapies and approaches

Work Group:Robert Sidbury, MD ^a : Co-chair, Wynnis L. Tom, MD ^b, James N. Bergman, MD ^c, Kevin D. Cooper, MD ^d, Robert A. Silverman, MD ^e, Timothy G. Berger, MD ^f, Sarah L. Chamlin, MD, MSCI ^g, David E. Cohen, MD ^h, Kelly M. Cordoro, MD ^f, Dawn M. Davis, MD ⁱ, Steven R. Feldman, MD, PhD ^j, Jon M. Hanifin, MD ^k, Alfons Krol, MD ^k, David J. Margolis, MD, PhD ^l, Amy S. Paller, MD ^g, Kathryn Schwarzenberger, MD ^m, Eric L. Simpson, MD ^k, Hywel C. Williams, DSc ⁿ, Craig A. Elmets, MD ^o, Julie Block, BA ^p, Christopher G. Harrod, MS ^q, Wendy Smith Begolka, MBS ^q,^⁎ , Lawrence F. Eichenfield, MD ^b : Co-chair
^a Department of Dermatology, Seattle Children's Hospital, Seattle, Washington
^b University of California, San Diego and Division of Pediatric and Adolescent Dermatology, Rady Children's Hospital, San Diego, California
^c Department of Dermatology and Skin Science, University of British Columbia, Vancouver, British Columbia, Canada
^d Department of Dermatology, Case Western University, Cleveland, Ohio
^e private practice, Fairfax, Virginia
^f Department of Dermatology, University of California San Francisco, San Francisco, California
^g Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois
^h Department of Dermatology, New York University School of Medicine, New York, New York
ⁱ Department of Dermatology, Mayo Clinic, Rochester, Minnesota
^j Department of Dermatology, Wake Forest University Health Sciences, Winston-Salem, North Carolina
^k Department of Dermatology, Oregon Health & Science University, Portland, Oregon
^l Department of Biostatistics and Epidemiology, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
^m Kaplan-Amonette Department of Dermatology, University of Tennessee Health Science Center, Memphis, Tennessee
ⁿ Centre of Evidence-Based Dermatology, Nottingham University Hospitals National Health Service Trust, Nottingham, United Kingdom
^o Department of Dermatology, University of Alabama at Birmingham, Birmingham, Alabama
^p National Eczema Association, San Rafael, California
^q American Academy of Dermatology, Schaumburg, Illinois

^∗Reprint requests: Wendy Smith Begolka, MBS, American Academy of Dermatology, 930 E Woodfield Rd, Schaumburg, IL 60173.


	Abstract

Atopic dermatitis is a common, chronic inflammatory dermatosis that can affect all age groups. This evidence-based guideline addresses important clinical questions that arise in its management. In this final section, treatments for flare prevention and adjunctive and complementary therapies and approaches are reviewed. Suggestions on use are given based on available evidence.

The full text of this article is available in PDF format.

Key words : aeroallergens, allergy testing, atopic dermatitis, calcineurin inhibitors, complementary therapy, corticosteroids, diet, education, flare, food allergy, topicals

Abbreviations used : AAD, ACD, AD, APT, HDM, IgE, ICD, NIAID, SCORAD, SPT, TCI, TCM, TCS, RCT

Outline

Prevention of disease flares

Educational interventions

Coexisting allergic disease and allergy testing (+)

Dietary interventions (+)

Environmental modifications

Other allergen-based interventions

Complementary therapies

Gaps in research

	Funding sources: None.
	The management of conflict of interest for this guideline series complies with the Council of Medical Specialty Societies' Code of Interactions with Companies . The authors' conflict of interest/disclosure statements appear at the end of this article.